blonanserin has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Begni, V; Gruca, P; Guidi, A; Lason, M; Litwa, E; Marchisella, F; Molteni, R; Paladini, MS; Papp, M; Riva, MA; Spero, V | 1 |
| Deriha, K; Furuse, K; Hashiguchi, H; Hashimoto, E; Ishii, T; Kawanishi, C; Kigawa, Y; Shiraishi, M; Tayama, M; Ukai, W | 1 |
| Baba, S; Enomoto, T; Hashimoto, T; Horisawa, T; Ono, M | 1 |
| Enomoto, T; Ikeda, K; Ikejiri, M; Iwamura, Y; Kiyoshi, A; Kotani, M; Matsumoto, A; Matsumoto, K; Murai, T; Nakako, T; Nakayama, T; Ogi, Y | 1 |
| Furukawa, H; Furukawa, K; Kan, QM; Nabeshima, T; Nagai, T; Noda, Y; Une, T | 1 |
6 other study(ies) available for blonanserin and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Behavioral and molecular effects of the antipsychotic drug blonanserin in the chronic mild stress model.
Topics: Animals; Antipsychotic Agents; Behavior, Animal; Brain; Cytoskeletal Proteins; Disease Models, Animal; Male; Maze Learning; Nerve Tissue Proteins; Oxidoreductases; Piperazines; Piperidines; Rats, Wistar; Stress, Psychological | 2021 |
Antidepressant activities of escitalopram and blonanserin on prenatal and adolescent combined stress-induced depression model: Possible role of neurotrophic mechanism change in serum and nucleus accumbens.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Brain-Derived Neurotrophic Factor; Citalopram; Corticosterone; Depression; Disease Models, Animal; Female; Hippocampus; Male; Nucleus Accumbens; Piperazines; Piperidines; Pregnancy; Rats; Social Behavior; Swimming | 2019 |
Blonanserin extensively occupies rat dopamine D3 receptors at antipsychotic dose range.
Topics: Animals; Antipsychotic Agents; Cells, Cultured; Cricetinae; Cricetulus; Disease Models, Animal; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Piperazines; Piperidines; Protein Binding; Rats, Sprague-Dawley; Receptors, Dopamine D3; Serotonin 5-HT2 Receptor Antagonists | 2015 |
The atypical antipsychotic blonanserin reverses (+)-PD-128907- and ketamine-induced deficit in executive function in common marmosets.
Topics: Animals; Antipsychotic Agents; Benzopyrans; Callithrix; Cognition Disorders; Disease Models, Animal; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Executive Function; Female; Ketamine; Male; Mental Recall; Oxazines; Piperazines; Piperidines | 2016 |
Effect of AD-5423 on animal models of schizophrenia: phencyclidine-induced behavioral changes in mice.
Topics: Animals; Disease Models, Animal; Immobilization; Male; Mice; Motor Activity; Phencyclidine; Piperazines; Piperidines; Schizophrenia | 2003 |